You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API inebilizumab

✉ Email this page to a colleague

« Back to Dashboard

Detailed excipient profiles for inebilizumab

Excipient focus: HISTIDINE

inebilizumab drug variants containing HISTIDINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing HISTIDINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HISTIDINE HYDROCHLORIDE MONOHYDRATE

inebilizumab drug variants containing HISTIDINE HYDROCHLORIDE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing HISTIDINE HYDROCHLORIDE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
>Company	>Ingredient	>NDC

Excipient focus: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE

inebilizumab drug variants containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

inebilizumab drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

inebilizumab drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TREHALOSE DIHYDRATE

inebilizumab drug variants containing TREHALOSE DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing TREHALOSE DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

inebilizumab drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Viela Bio Inc	inebilizumab	72677-551
Horizon Therapeutics USA Inc	inebilizumab	75987-150
>Company	>Ingredient	>NDC

inebilizumab drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.